Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SHR-1819 by Jiangsu Hengrui Medicine for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
SHR-1819 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According...
Data Insights
SHR-1819 by Jiangsu Hengrui Medicine for Sinusitis: Likelihood of Approval
SHR-1819 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Sinusitis. According to GlobalData, Phase...